Get in Touch

We supported a top 10 pharma in creating meaningful and actionable Competitor Intelligence insights in the gene therapy space​

Client Challenge

Haemophilia and GT environment ​is in its infancy, with very few approved available products

Competitor actions and the results ​ of individual HTAs/coverage ​ decisions can have a significant ​ impact on the wider landscape​

​Our client was keen to understand competitors’ pricing and market access activities as well as a general overview ​ of the evolving gene therapy treatment environment, using this to support management decision making​

P4A Solution

P4A developed a report that incorporated six key areas of strategic importance​

  1. GT policy & HTA processes: today & future​
  2. General competitor corporate news​
  3. Competitor pricing strategy and HTA outcomes, access models​
  4. Competitor strategies on stakeholder engagement and site selection​
  5. Competitor manufacturing, logistics & supply model​
  6. Competitor GT organizational build​

The Successful Outcome

Global and European management teams ​were appraised of competitor activity and were better able to shape asset development

Confidence in management decision making​

P4A fully met our needs and showed both flexibility and strong technical capabilities to deliver a polished product on time and budget!​ ​
PHI Senior Director Rare Disease​
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact